Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 272

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn

Open access
Spechler, Stuart J., Hunter, John G., Jones, Karen M., Lee, Robert, Smith, Brian R., Mashimo, Hiroshi, Sanchez, Vivian M., Dunbar, Kerry B., Pham, Thai H., Murthy, Uma K., Kim, Taewan, Jackson, Christian S., Wallen, Jason M., von Rosenvinge, Erik C., Pearl, Jonathan P., Laine, Loren, Kim, Anthony W., Kaz, Andrew M., Tatum, Roger P., Gellad, Ziad F., Lagoo-Deenadayalan, Sandhya, Rubenstein, Joel H., Ghaferi, Amir A., Lo, Wai-Kit, Fernando, Ronald S., Chan, Bobby S., Paski, Shirley C., Provenzale, Dawn, Castell, Donald O., Lieberman, David, Souza, Rhonda F., Chey, William D., Warren, Stuart R., Davis-Karim, Anne, Melton, Shelby D., Genta, Robert M., Serpi, Tracey, Biswas, Kousick, Huang, Grant D. · 2019 · New England Journal of Medicine

Abstract

BACKGROUND: Heartburn that persists despite proton-pump inhibitor (PPI) treatment is a frequent clinical problem with multiple potential causes. Treatments for PPI-refractory heartburn are of unproven efficacy and focus on controlling gastroesophageal reflux with reflux-reducing medication (e.g., baclofen) or antireflux surgery or on dampening visceral hypersensitivity with neuromodulators (e.g., desipramine). METHODS: Patients who were referred to Veterans Affairs (VA) gastroenterology clinics for PPI-refractory heartburn received 20 mg of omeprazole twice daily for 2 weeks, and those with persistent heartburn underwent endoscopy, esophageal biopsy, esophageal manometry, and multichannel intraluminal impedance-pH monitoring. If patients were found to have reflux-related heartburn, we randomly assigned them to receive surgical treatment (laparoscopic Nissen fundoplication), active medical treatment (omeprazole plus baclofen, with desipramine added depending on symptoms), or control medical treatment (omeprazole plus placebo). The primary outcome was treatment success, defined as a decrease of 50% or more in the Gastroesophageal Reflux Disease (GERD)-Health Related Quality of Life score (range, 0 to 50, with higher scores indicating worse symptoms) at 1 year. RESULTS: A total of 366 patients (mean age, 48.5 years; 280 men) were enrolled. Prerandomization procedures excluded 288 patients: 42 had relief of their heartburn during the 2-week omeprazole trial, 70 did not complete trial procedures, 54 were excluded for other reasons, 23 had non-GERD esophageal disorders, and 99 had functional heartburn (not due to GERD or other histopathologic, motility, or structural abnormality). The remaining 78 patients underwent randomization. The incidence of treatment success with surgery (18 of 27 patients, 67%) was significantly superior to that with active medical treatment (7 of 25 patients, 28%; P = 0.007) or control medical treatment (3 of 26 patients, 12%; P<0.001). The difference in the incidence of treatment success between the active medical group and the control medical group was 16 percentage points (95% confidence interval, -5 to 38; P = 0.17). CONCLUSIONS: Among patients referred to VA gastroenterology clinics for PPI-refractory heartburn, systematic workup revealed truly PPI-refractory and reflux-related heartburn in a minority of patients. For that highly selected subgroup, surgery was superior to medical treatment. (Funded by the Department of Veterans Affairs Cooperative Studies Program; ClinicalTrials.gov number, NCT01265550.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1811424

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 272

Metadata

Authors
Spechler, S. J., Hunter, J. G., Jones, K. M., Lee, R., Smith, B. R., Mashimo, H., Sanchez, V. M., Dunbar, K. B., Pham, T. H., Murthy, U. K., Kim, T., Jackson, C. S., Wallen, J. M., von Rosenvinge, E. C., Pearl, J. P., Laine, L., Kim, A. W., Kaz, A. M., Tatum, R. P., Gellad, Z. F., Lagoo-Deenadayalan, S., Rubenstein, J. H., Ghaferi, A. A., Lo, W.-K., Fernando, R. S., Chan, B. S., Paski, S. C., Provenzale, D., Castell, D. O., Lieberman, D., Souza, R. F., Chey, W. D., Warren, S. R., Davis-Karim, A., Melton, S. D., Genta, R. M., Serpi, T., Biswas, K., & Huang, G. D.
Venue
New England Journal of Medicine
Published
2019-10-17
Volume
381
Issue
16
Pages
1513-1523
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2980759431
Cited by
272
References
29
FWCI
25.62
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn. https://app.cochat.ai/papers/10.1056/nejmoa1811424
The paper
Spechler, S. J., Hunter, J. G., Jones, K. M., Lee, R., Smith, B. R., Mashimo, H., Sanchez, V. M., Dunbar, K. B., Pham, T. H., Murthy, U. K., Kim, T., Jackson, C. S., Wallen, J. M., von Rosenvinge, E. C., Pearl, J. P., Laine, L., Kim, A. W., Kaz, A. M., Tatum, R. P., . . . Huang, G. D. (2019). Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1811424

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.